George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 486.00
Bid: 484.00
Ask: 488.00
Change: 16.00 (3.40%)
Spread: 4.00 (0.826%)
Open: 465.00
High: 486.00
Low: 465.00
Prev. Close: 470.00
TET Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update

7 Apr 2020 07:00

RNS Number : 9761I
Treatt PLC
07 April 2020
 

 

 

7 April 2020

 

TREATT PLC

("Treatt" or "the Group")

 

Trading update for the half year ended 31 March 2020

 

Treatt, the manufacturer and supplier of innovative ingredient solutions for the beverage, flavour, fragrance and consumer product industries today publishes a trading update for the half year ended 31 March 2020 (the "Period").

 

Treatt plays a critical role in the food, beverage and cleaning supply chains and order intake in recent weeks has been strong as a number of our customers respond to increased demand for beverages consumed at home and cleaning products (such as liquid hand soaps and floor cleaning products) which are of particular importance at this time.

 

As such, the Board can confirm that, to date, there has not been any adverse effect on the trading performance of the Group due to COVID-19 and the Group is currently trading in line with the Board's expectations.

 

The business has taken, and will continue to take, timely action to protect the health and safety of all its employees across the Group as well as doing all it can to support the communities in which it operates. We received early indications of the likely steps that would follow from our colleagues in Shanghai, where our office remained open, albeit operating for one month on a staff rota, and whom we are pleased to say have now all returned to work. In both the UK and US all non-essential staff are working from home and manufacturing continues, working within government guidelines and with appropriate health protection and wellbeing measures in place.

 

As previously reported, we expected the sharp fall in citrus raw material prices in the last financial year to continue to impact upon revenue in the first half of the current financial year. Consequently, whilst in-line with expectations, revenue for the Period is expected to be approximately 5.1% lower as compared with the same period in the prior year (5.6% lower in constant currency).

 

Whilst citrus remains a significant part of the Group's business, there was good growth in reported revenue from fruit and vegetables (up 9.4%), tea (up 47.5%) and health and wellness (incl. sugar reduction) (up 19.9%). The vast majority of Treatt's portfolio is targeted at the growing demand from consumers for more natural and clean-label products which is helping to drive our financial performance as well as our encouraging opportunity pipeline. Our customers continue to look to product innovation to differentiate their products, launch new products and categories and refresh existing products. Treatt continues to benefit from the valuable role our services play in helping meet these demands with the Group's new product development programme progressing well with market entry points currently being explored.

 

Building work on our new facility in the UK has inevitably slowed as a consequence of the COVID-19 pandemic. We now expect that our UK relocation may not take place until 2021 but at this stage it is not possible to confirm a new definitive timescale. The delay to our UK relocation will not affect our ability to meet customer orders in the short to medium term but such a delay does enable the Group to preserve cash during this period of uncertainty. At the end of the Period the Group had net cash of £6.5m and total bank facilities of £25.0m, of which £24.9m remains undrawn.

 

As previously reported, the expansion of our US manufacturing facility was completed last year and is now fully operational. Our capacity for products in our fast-growing fruit and vegetables, health and wellness and tea product categories has now doubled and is coming on stream in time for the new crop season as growth in these categories continues from both new and existing customers.

 

The Group has a hedging strategy in place to try to minimise the impact of exchange rate movements over the course of a financial year though there can be material effects over shorter periods of time. During the Period there was a strengthening in the USD/GBP exchange rate and, as a result, the Board anticipates a net positive FX impact on the results for the Period of approximately £0.6m.

 

Outlook

The focus we have made over recent years on the culture in the business means that we have an incredibly strong and committed team of employees who we know will shine in these exceptional times, whilst protecting the health and safety of each other and the wider communities in which we operate.

 

The business is both trading well and is financially robust; we are encouraged by our order book and current demand as we move into our peak seasonal period. Also, and as expected, citrus raw material prices are firming once more, which should result in a stronger performance from our citrus category in the second half of the financial year. Whilst it is difficult to determine the likely impact of COVID-19 on the demand for the Group's products in the coming months, our early experience has shown demand to be robust and at this time, trading remains in line with the Board's expectations.

 

It is currently expected that Treatt's half year results for the six months ended 31 March 2020 will be announced on 12 May 2020.

 

Enquiries:

Treatt plc +44 (0)1284 702500

Daemmon Reeve Chief Executive Officer

Richard Hope Chief Financial Officer

 

Broker

Investec Investment Banking

Patrick Robb +44 (0)20 7597 5970

David Anderson

Alex Wright

 

Public relations

DRD Partnership

Lawrence Dore +44 (0)20 3951 0349

 

About the Group

Treatt is a global, independent supplier of innovative ingredient solutions for the flavour, fragrance and multinational consumer product industries, particularly in the beverage sector. Renowned for its technical expertise and knowledge of ingredients, their origins and market conditions, Treatt is recognised as a leader in its field.

 

The Group employs over 300 staff in Europe, North America, Africa and Asia and has manufacturing facilities in the UK, USA and Kenya. Its international footprint enables the Group to deliver powerful and integrated solutions for the food, beverage and fragrance industries across the globe.

 

 

For further information about the Group, visit www.treatt.com.

 

 

CAUTIONARY STATEMENT ABOUT FORWARD-LOOKING STATEMENTS

This announcement contains forward-looking statements that are subject to risk factors associated with, among other things, the economic and business circumstances occurring from time to time in the countries, sectors and markets in which the Group operates. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a wide range of variables which could cause actual results to differ materially from those currently anticipated. No assurances can be given that the forward-looking statements in this announcement will be realised. The forward-looking statements reflect the knowledge and information available at the date of preparation of this announcement and the Group undertakes no obligation to update these forward-looking statements. Nothing in this announcement should be construed as a profit forecast.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFLFITSVIRIII
Date   Source Headline
29th Dec 20177:00 amRNSVoting Rights and Captial
22nd Dec 20179:01 amRNSHolding(s) in Company
21st Dec 20173:23 pmRNSHolding(s) in Company
19th Dec 20173:46 pmRNSDirector/PDMR Shareholding
19th Dec 20173:20 pmRNSHolding(s) in Company
18th Dec 20173:41 pmRNSResult of General Meeting
14th Dec 201710:41 amRNSAnnual Financial Report
6th Dec 20175:04 pmRNSHolding(s) in Company
1st Dec 20174:16 pmRNSBlock Listing Six Monthly Return
1st Dec 20177:00 amRNSTotal Voting Rights
28th Nov 20177:00 amRNSPlacing to raise £21.6 million
28th Nov 20177:00 amRNSFinal Results
10th Nov 201712:34 pmRNSHolding(s) in Company
2nd Oct 20177:00 amRNSTrading Update
29th Sep 20175:14 pmRNSTotal Voting Rights
26th Sep 20178:54 amRNSHolding(s) in Company
21st Sep 201712:23 pmRNSHolding(s) in Company
21st Aug 201711:09 amRNSDirector/PDMR Shareholding
2nd Aug 20175:07 pmRNSTotal Voting Rights
20th Jul 20171:50 pmRNSDirector/PDMR Shareholding
5th Jun 20171:35 pmRNSBlock Listing Six Monthly Return
23rd May 20179:30 amRNSBlock Listing Application
11th May 20174:05 pmRNSHolding(s) in Company
11th May 20174:01 pmRNSDirector/PDMR Shareholding
10th May 20172:53 pmRNSHolding(s) in Company
9th May 20177:00 amRNSHalf-year Report
5th Apr 20174:41 pmRNSHolding(s) in Company
3rd Apr 20175:25 pmRNSDirector/PDMR Shareholding
31st Mar 20173:57 pmRNSTotal Voting Rights
30th Mar 20177:00 amRNSTrading Statement
27th Mar 20179:30 amRNSHolding(s) in Company
24th Mar 20173:44 pmRNSDirector/PDMR Shareholding
2nd Mar 20174:50 pmRNSHolding(s) in Company
23rd Feb 20177:00 amRNSDirector/PDMR Shareholding
23rd Feb 20177:00 amRNSTrading Statement
20th Feb 20174:03 pmRNSDirector/PDMR Shareholding
14th Feb 20178:15 amRNSHolding(s) in Company
10th Feb 20179:41 amRNSHolding(s) in Company
1st Feb 20172:19 pmRNSDirector/PDMR Shareholding
30th Jan 20175:58 pmRNSNotification of a Transaction of a Director
27th Jan 20174:42 pmRNSResult of AGM
27th Jan 20177:15 amRNSTrading Statement
30th Dec 20167:00 amRNSAnnual Information Update
30th Dec 20167:00 amRNSTotal Voting Rights
22nd Dec 20163:11 pmRNSUpdate on Site Relocation
20th Dec 201610:26 amRNSDirector/PDMR Shareholding
13th Dec 20161:11 pmRNSNotification of Transactions of Directors
9th Dec 20163:05 pmRNSAnnual Financial Report
5th Dec 20164:35 pmRNSBlock listing Interim Review
1st Dec 20162:55 pmRNSVoting Rights and Capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.